6li2
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Crystal structure of GPR52 ligand free form with rubredoxin fusion== | |
- | + | <StructureSection load='6li2' size='340' side='right'caption='[[6li2]], [[Resolution|resolution]] 2.80Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[6li2]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6LI2 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6LI2 FirstGlance]. <br> | |
- | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=OLC:(2R)-2,3-DIHYDROXYPROPYL+(9Z)-OCTADEC-9-ENOATE'>OLC</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | |
- | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6li2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6li2 OCA], [http://pdbe.org/6li2 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6li2 RCSB], [http://www.ebi.ac.uk/pdbsum/6li2 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6li2 ProSAT]</span></td></tr> |
+ | </table> | ||
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/GPR52_HUMAN GPR52_HUMAN]] Gs-coupled receptor activated by antipsychotics reserpine leading to an increase in intracellular cAMP and its internalization (PubMed:24587241). May play a role in locomotor activity through modulation of dopamine, NMDA and ADORA2A-induced locomotor activity. These behavioral changes are accompanied by modulation of the dopamine receptor signaling pathway in striatum (PubMed:24587241). Modulates HTT level via cAMP-dependent but PKA independent mechanisms throught activation of RAB39B that translocates HTT to the endoplasmic reticulum, thus avoiding proteasome degradation (PubMed:25738228).<ref>PMID:24587241</ref> <ref>PMID:25738228</ref> | ||
+ | == References == | ||
+ | <references/> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Large Structures]] | ||
+ | [[Category: Han, G W]] | ||
+ | [[Category: Lin, X]] | ||
+ | [[Category: Luo, Z P]] | ||
+ | [[Category: Xu, F]] | ||
+ | [[Category: Apo form]] | ||
+ | [[Category: Class some]] | ||
+ | [[Category: Human gpr52 receptor]] | ||
+ | [[Category: Lcp]] | ||
+ | [[Category: Membrane protein]] | ||
+ | [[Category: Orphan gpcr]] | ||
+ | [[Category: Rubredoxin]] |
Revision as of 09:14, 26 February 2020
Crystal structure of GPR52 ligand free form with rubredoxin fusion
|
Categories: Large Structures | Han, G W | Lin, X | Luo, Z P | Xu, F | Apo form | Class some | Human gpr52 receptor | Lcp | Membrane protein | Orphan gpcr | Rubredoxin